64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending
It plays a role in your risk of developing health issues like osteoporosis down the road
It is particularly effective when taken in conjunction with sports, as it increases fat burning during exercise
Al-Ghadban S, Evancio JV, Alfiscar PEF, Herbst KL
Why the caveats: Most human data is observational, not randomized controlled trials designed to prove prevents dementia. So far, we cannot definitively say GLP-1 RAs prevent Alzheimers
Require prescriptions and oversight from licensed healthcare providers